Background and Study Aims: The reason for the increased risk of pancre
atitis after endoscopic retrograde cholangiopancreatography (ERCP) in
patients with sphincter of Oddi dysfunction is not known. This study s
ought to determine whether pancreatic sphincter hypertension might exp
lain some of the increased risk.Patients and Methods: The incidence of
pancreatitis was determined from a cohort of patients who underwent p
ancreatic sphincter manometry. Additional data collected included: pan
creatic and biliary sphincter manometry results, distal bible duct dia
meter, chronic pancreatitis grade by pancreatography, and endoscopic t
reatments. Results: Ten of 32 patients (31%) with pancreatic sphincter
hypertension developed post-ERCP pancreatitis, compared to one of 33
(3%) with normal pancreatic manometry (P = 0.002). Patient with pancre
atic sphincter hypertension were more likely to undergo endoscopic tre
atments (88%) compared to those with normal manometry (27%) (P = 0.001
). The distal bile duct diameter was significantly smaller (4.5 +/- 0.
5 mm) in patients who developed post-ERCP pancreatitis than in those w
ho did not (6.2 +/- 0.3) (P = 0.025). Patients with small distal bile
duct diameters (< 5 mm) were three times more likely to develop post-E
RCP pancreatitis than those with larger ducts (relative risk [RR] 3.1,
95% confidence interval [CI] 0.9, 10.7). Patients with pancreatic sph
incter hypertension were ten times more likely to develop post-ERCP pa
ncreatitis than those with normal pancreatic manometry (RR 10.3, 95% C
I 1.5, 76.0). In patients with a small bile duct size, pancreatic sphi
ncter hypertension substantially increased the risk compared to those
with normal manometry (RR 18.1, 95% CI 1.1, 287.6). Conclusions: Pancr
eatic sphincter hypertension greatly increases the risk of post-ERCP p
ancreatitis in patients undergoing treatment or evaluation, or both, f
or sphincter of Oddi dysfunction.